Literature DB >> 18155658

Ubiquitin-dependent and -independent proteasomal degradation of hepatitis B virus X protein.

Jung-Hwan Kim1, Sook-Young Sohn, T S Benedict Yen, Byung-Yoon Ahn.   

Abstract

The hepatitis B virus X protein (HBX) plays key regulatory roles in viral replication and the development of hepatocellular carcinoma. HBX is an unstable protein; its instability is attributed to rapid degradation through the ubiquitin-proteasome pathway. Here, we show that the middle and carboxyl-terminal domains of HBX, independently fused to GFP, render the recombinant proteins susceptible to proteasomal degradation, while the amino-terminal domain has little effect on the ubiquitination or stability of HBX. Mutation of any single or combination of up to five of six lysine residues, all located in the middle and carboxyl-terminal domain, did not prevent HBX from being ubiquitinated, ruling out any specific lysine as the sole site of ubiquitination. Surprisingly, HBX in which all six lysines were mutated and showed no evidence of ubiquitination, was still susceptible to proteasomal degradation. These results suggest that both ubiquitin-dependent and -independent proteasomal degradation processes are operative in HBX turnover.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18155658     DOI: 10.1016/j.bbrc.2007.12.070

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  16 in total

1.  Mitotic down-regulation of p190RhoGAP is required for the successful completion of cytokinesis.

Authors:  Sergio A Sánchez Manchinelly; Joyce Agati Miller; Ling Su; Tsuyoshi Miyake; Lisa Palmer; Masahito Mikawa; Sarah J Parsons
Journal:  J Biol Chem       Date:  2010-06-09       Impact factor: 5.157

2.  p53 Promotes proteasome-dependent degradation of oncogenic protein HBx by transcription of MDM2.

Authors:  Lingling Xian; Jing Zhao; Jia Wang; Zhou Fang; Bo Peng; Wenzhang Wang; Xiaona Ji; Long Yu
Journal:  Mol Biol Rep       Date:  2009-10-16       Impact factor: 2.316

3.  Roles of the two distinct proteasome pathways in hepatitis C virus infection.

Authors:  Ikuo Shoji
Journal:  World J Virol       Date:  2012-04-12

4.  Inhibition of hepatitis B virus replication by cIAP2 involves accelerating the ubiquitin-proteasome-mediated destruction of polymerase.

Authors:  Zekun Wang; Jinjing Ni; Jianhua Li; Bisheng Shi; Yang Xu; Zhenghong Yuan
Journal:  J Virol       Date:  2011-08-24       Impact factor: 5.103

Review 5.  Ubiquitin-independent proteasomal degradation during oncogenic viral infections.

Authors:  Jiwon Hwang; Laura Winkler; Robert F Kalejta
Journal:  Biochim Biophys Acta       Date:  2011-06-06

6.  Identification of STAU1 as a regulator of HBV replication by TurboID-based proximity labeling.

Authors:  Xia-Fei Wei; Shu-Ying Fan; Yu-Wei Wang; Shan Li; Shao-Yuan Long; Chun-Yang Gan; Jie Li; Yu-Xue Sun; Lin Guo; Pei-Yun Wang; Xue Yang; Jin-Lan Wang; Jing Cui; Wen-Lu Zhang; Ai-Long Huang; Jie-Li Hu
Journal:  iScience       Date:  2022-05-18

7.  Hepatocyte Factor JMJD5 Regulates Hepatitis B Virus Replication through Interaction with HBx.

Authors:  Takahisa Kouwaki; Toru Okamoto; Ayano Ito; Yukari Sugiyama; Kazuo Yamashita; Tatsuya Suzuki; Shinji Kusakabe; Junki Hirano; Takasuke Fukuhara; Atsuya Yamashita; Kazunobu Saito; Daisuke Okuzaki; Koichi Watashi; Masaya Sugiyama; Sachiyo Yoshio; Daron M Standley; Tatsuya Kanto; Masashi Mizokami; Kohji Moriishi; Yoshiharu Matsuura
Journal:  J Virol       Date:  2016-01-20       Impact factor: 5.103

8.  The X-linked tumor suppressor TSPX interacts and promotes degradation of the hepatitis B viral protein HBx via the proteasome pathway.

Authors:  Tatsuo Kido; Jing-Hsiung James Ou; Yun-Fai Chris Lau
Journal:  PLoS One       Date:  2011-07-29       Impact factor: 3.240

9.  An autophagosome-based therapeutic vaccine for HBV infection: a preclinical evaluation.

Authors:  Meng Xue; Fei Fan; Lei Ding; Jingyu Liu; Shu Su; Pengfei Yin; Meng Cao; Wei Zhao; Hong-ming Hu; Lixin Wang
Journal:  J Transl Med       Date:  2014-12-20       Impact factor: 5.531

Review 10.  Broad-spectrum antiviral agents.

Authors:  Jun-Da Zhu; Wen Meng; Xiao-Jia Wang; Hwa-Chain R Wang
Journal:  Front Microbiol       Date:  2015-05-22       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.